FDA inspection
Aspire Pharmaceuticals, Inc.: FDA inspection ending May 21, 2004
FDA inspection 327516 · No Action Indicated (NAI) · Somerset, NJ
Key facts
| Inspection ID | 327516 |
|---|---|
| Firm | Aspire Pharmaceuticals, Inc. |
| FEI number | 3003159106 |
| Address | 37 & 41 Veronica Ave |
| City | Somerset |
| State | NJ |
| ZIP | 08873-6800 |
| Fiscal year | 2004 |
| Inspection end date | May 21, 2004 |
| Classification | No Action Indicated (NAI) |
| Project area | Food Compos, Stds, Labeling & Economics |
| Product type | Food/Cosmetics |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data